Gilead Sciences, Inc.

67
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US3755581036
USD
122.62
-1.29 (-1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
28,727.00
27,058.00
27,085.00
27,372.00
24,642.00
22,322.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
28,727.00
27,058.00
27,085.00
27,372.00
24,642.00
22,322.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
977.00
944.00
935.00
1,001.00
984.00
995.00
General and Administration Expenses
6,000.00
5,537.00
5,673.00
5,207.00
4,832.00
4,381.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
18,067.00
17,314.00
16,328.00
17,171.00
14,198.00
17,362.00
Operating Profit (PBDIT) excl Other Income
10,660.00
9,744.00
10,757.00
10,201.00
10,444.00
4,960.00
Other Income
271.00
366.00
205.00
600.00
-4,850.00
773.00
Operating Profit (PBDIT)
13,698.00
12,803.00
13,065.00
12,851.00
7,074.00
7,137.00
Interest
977.00
944.00
935.00
1,001.00
984.00
995.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
2,767.00
2,693.00
2,103.00
2,050.00
1,480.00
1,404.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
690.00
6,859.00
5,814.00
8,278.00
1,669.00
5,160.00
Provision for Tax
210.00
1,246.00
1,248.00
2,077.00
1,580.00
-204.00
Profit After Tax
480.00
5,665.00
4,592.00
6,225.00
123.00
5,386.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.38
4.50
3.64
4.93
0.10
4.22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 6.17% vs -0.10% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 9.40% vs -9.42% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 3.50% vs 0.96% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -91.53% vs 23.37% in Dec 2023

Compare Profit and Loss Results of Gilead Sciences, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
28,727.00
33,232.00
-4,505.00
-13.56%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
28,727.00
33,232.00
-4,505.00
-13.56%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
977.00
3,224.00
-2,247.00
-69.70%
General and Administration Expenses
6,000.00
7,096.00
-1,096.00
-15.45%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
18,067.00
24,671.00
-6,604.00
-26.77%
Operating Profit (PBDIT) excl Other Income
10,660.00
8,561.00
2,099.00
24.52%
Other Income
271.00
173.00
98.00
56.65%
Operating Profit (PBDIT)
13,698.00
14,078.00
-380.00
-2.70%
Interest
977.00
3,224.00
-2,247.00
-69.70%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
2,767.00
5,592.00
-2,825.00
-50.52%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
690.00
4,609.00
-3,919.00
-85.03%
Provision for Tax
210.00
519.00
-309.00
-59.54%
Profit After Tax
480.00
4,090.00
-3,610.00
-88.26%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.3825
7.5601
-7.18
-94.94%
Profit And Loss - Net Sales
Net Sales 28,727.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 6.17% vs -0.10% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10,660.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 9.40% vs -9.42% in Dec 2023

Profit And Loss - Interest
Interest 977.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.50% vs 0.96% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 480.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -91.53% vs 23.37% in Dec 2023